June 2019


Research identifies biomarker for myocarditis
A research collaboration led by Mayo Clinic investigators identified the first biomarker for myocarditis, sera soluble ST2, and found it significantly elevated in men ≤ 50 years, compared with healthy controls and women.

Augmented and virtual reality technologies harnessed for innovative cardiac care
Mayo Clinic is rapidly developing augmented and virtual reality ― artificial intelligence technologies ― to improve heart visualizations and create biopatches for arrhythmia therapy.

Artificial intelligence helps predict the presence of asymptomatic left ventricular dysfunction
Mayo researchers use convolutional neural networks to analyze electrocardiograms for silent subclinical, metabolic or structural abnormalities that may predict the presence of asymptomatic left ventricular dysfunction.

Mitral valve surgery with septal myectomy may increase risk for patients with hypertrophic cardiomyopathy
A retrospective study supports the need for increasing surgical experience with septal myectomy for obstructive hypertrophic cardiomyopathy to further improve outcomes.

Center for Regenerative Medicine provides dedicated infrastructure for regenerative technologies
Mayo Clinic's cardiopoietic stem cell experience has created a team with unique expertise in product development, manufacturing, quality assurance and FDA-regulated clinical trial execution that advances regenerative medicine.

Culturally relevant mobile app improves health in African American community
Fifty African American adults participated in a 10-week study that included podcasts and multimedia educational modules delivered via app. Results show several objectively measured positive outcomes for cardiovascular health.

See all Cardiovascular Medicine and Cardiovascular Surgery Clinical Trials at Mayo Clinic

Back to Top


Current Applications and Future of Artificial Intelligence in Cardiology
July 19-20, 2019, in San Francisco
Topics include the most common methods for supervised and unsupervised machine learning and potential applications of artificial intelligence as applied to prognostic tools, clinical decision-making, imaging processing and informatics.

Echocardiographic Symposium at Vail: State-of-the-Art Review, Live Scanning With Emphasis on Multimodality Imaging With Cardiac CT & MRI
July 22-25, 2019, in Vail, Colo.
Course highlights include strain imaging, congenital heart disease, 3D transesophageal echocardiography, hands-on scanning opportunities, and imaging in echocardiogram, cardiac CT and MRI.

Advanced Catheter Ablation: New Tips, Techniques and Technologies for Complex Arrhythmias
Sept. 7-10, 2019, in Chicago
Focus includes mechanisms underlying cardiac arrhythmias amenable to ablation, cardiac anatomy's role in the genesis of arrhythmias and ablation strategy, and optimal mapping and ablation techniques for specific arrhythmias.

​​​​See all Cardiovascular Medicine CME courses


In the Video Center

Good news/bad news: Mayo Clinic commentary on what to expect from the ISCHEMIA trial
Cardiologist Raymond J. Gibbons, M.D., discusses the success and cautionary indicators of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial.

View Cardiovascular Diseases specialty and Grand Rounds presentations

Back to Top

Connect With Us

Twitter icon

Follow us on Twitter
Receive real-time news and thought-leading insight

Check us out on Medscape Cardiology
Mayo Clinic joins forces with Medscape Cardiology to bring you the latest perspective on clinical trials, patient care and news.

Consults & Referrals

Phoenix/Scottsdale, Arizona


Jacksonville, Florida

Rochester, Minnesota

Eau Claire, Wisconsin   

Online Referrals


Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905